ArticleBlood2025

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Petra Nygrén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.